Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF12A
NM
Basal B
FTase Inhibitor I
Ftase
MAPK
12365.167
uM
inf
inf
1.0500 1.0500 0.0000 -0.0137
-0.2379
2.0273
HCC1954
HER2amp
Basal A
SB-3CT
MMP2/9
MMP
11055.144
uM
inf
inf
0.7776 0.7776 0.0000 0.0714
0.3204
1.6716
CAMA-1
HR+
Luminal
Trametinib
MEK
MAPK
9210.024
uM
inf
1.21970
0.6092 0.5429 0.5888 0.0970
0.9466
0.8697
MCF 10F
NM
-
PD184352
MEK
MAPK
12254.155
uM
inf
inf
0.9696 0.9696 0.0000 0.0271
-0.1748
1.8150
MCF 10A
NM
Basal B
ICRF-193
TOP2
TOP
11056.151
uM
inf
0.04801
0.5349 0.5474 2.0247 0.2393
0.9850
3.0292
SUM159PT
TNBC
Basal B
Sulindac sulfide
COX1/2
COX
10520.136
uM
inf
inf
0.9767 0.9767 0.0000 -0.0015
0.0597
4.0331
BT-474
HER2amp
Luminal
Nilotinib
ABL
nRTK
12178.145
uM
inf
inf
1.0500 1.0500 0.0000 0.0369
0.0948
0.6127
SUM159PT
TNBC
Basal B
TAPI-0
TACE/Collagenase
7531.096
uM
inf
inf
0.8694 0.8694 0.0000 0.0391
0.3982
3.5504
184B5
NM
Basal
Taxol
TUBB
TUBB
12979.002
uM
inf
0.00871
0.5987 0.6417 4.9974 0.2293
0.6910
1.3178
BT-474
HER2amp
Luminal
Nilotinib
ABL
nRTK
12291.17
uM
inf
inf
0.6458 0.6458 0.0000 0.2392
0.3142
0.5585
LY2
HR+
Luminal
SB-3CT
MMP2/9
MMP
10816.144
uM
inf
inf
0.9453 0.9453 0.0000 -0.0111
-0.0185
0.9146
BT-474
HER2amp
Luminal
Nilotinib
ABL
nRTK
12056.145
uM
inf
inf
0.9538 0.9538 0.0000 0.0958
0.3538
0.8365
HCC38
TNBC
Basal B
Purvalanol A
CDK1
CDK
7468.067
uM
inf
14.3580
0.7721 0.8436 4.9310 0.0226
0.7090
1.3847
AU565
HER2amp
Luminal
Dichloroacetate
PDK
PDK
13030.176
uM
inf
inf
0.8188 0.8188 0.0000 0.0150
0.5497
0.9892
HCC2185
TNBC
Luminal
FR180204
ERK1/2
MAPK
12192.161
uM
inf
inf
0.8011 0.8011 0.0000 0.0270
0.5359
0.5555
SUM159PT
TNBC
Basal B
TCS PIM-1 1
Pim kinase
PIM
11057.135
uM
inf
30.93790
0.6673 0.6670 4.9977 0.0270
0.9663
3.9340
HCC38
TNBC
Basal B
Sirolimus
MTOR
MTOR
7469.069
uM
inf
0.00397
0.3547 0.5089 0.6135 0.3258
0.8425
1.8642
HCC2185
TNBC
Luminal
PS-1145
IKK
NFKB
7463.065
uM
inf
35.55020
0.7381 0.7589 4.9874 0.0873
0.7220
0.5226
MCF7
HR+
Luminal
Trametinib
MEK
MAPK
7874.05
uM
inf
inf
0.9256 0.9256 0.0000 0.0249
0.5118
1.5863
MCF7
HR+
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7492.095
uM
inf
inf
0.7935 0.7935 0.0000 0.2394
-0.1467
1.0194
HCC1187
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
7433.098
uM
inf
inf
0.9581 0.9581 0.0000 0.0404
0.1069
1.1392
HCC1187
TNBC
Basal A
Lapatinib
EGFR/HER2
ErbB
7431.098
uM
inf
0.87832
0.8139 0.8296 4.9840 0.0429
0.8393
1.5161
HCC3153
TNBC
Basal A
Dichloroacetate
PDK
PDK
13733.176
uM
inf
inf
0.8129 0.8129 0.0000 0.0958
0.1866
0.7155
MDA-MB-231
TNBC
Basal B
Trametinib
MEK
MAPK
7892.012
uM
inf
0.05174
0.5884 0.6799 2.1441 0.1234
0.9280
2.3881
HCC38
TNBC
Basal B
FR180204
ERK1/2
MAPK
10578.137
uM
inf
inf
0.8466 0.8466 0.0000 0.0871
-0.0040
1.8268